Rolls out slew of additional measures to ensure ease of doing business for InvITs and REITs
SEBI cuts trading lot size ofprivately placed InvITs to ₹25 lakhs
Read Also
- Regeneron Pharma, Super Micro Computer And Global Payments Are Among Top 10 Large Cap Losers Last Week (Sept 23-Sept 27): Are The Others In Your Portfolio?
- Republican Congressional Candidate's Peculiar Tactic: Posing With A Stand-In Family
- Hurricane Helene Exposes Vulnerability Of Florida's Home Insurance Market
- Chinese Stocks Dominate - JD.com And Temu Parent PDD Are Among Top 10 Large Cap Gainers Last Week (Sept 23-Sept 27): Are The Others In Your Portfolio?
- Centre proposes 2022-23 as new base year for GDP computation
- Here's How Elon Musk Has Become A Pro-Trump Political Influencer Through Social Media
- This Minimalist Lamp Lets You Pick From 16 Million+ Lighting Colors for Maximum Productivity
- Video Shows 2,000-Pound Bombs Used In Israeli Military's Assault On Hezbollah Leader Nasrallah
- Hurricane Helene Devastates Southeastern U.S., Slamming Infrastructure And Leaving Millions Powerless
- Hurricane Helene Devastates Southeastern U.S., Slamming Infrastructure And Leaving Millions Powerless
Latest The Hindu BusinessLine
- Centre proposes 2022-23 as new base year for GDP computation
- SEBI cuts trading lot size ofprivately placed InvITs to ₹25 lakhs
- SEBI cuts trading lot size ofprivately placed InvITs to ₹25 lakhs
- PLI push: Govt may ease public procurement rules for new, innovative products
- PLI push: Govt may ease public procurement rules for new, innovative products
- Air India, SpiceJet duopoly ends, airports can now provide security service to foreign airlines
- SEBI ushers in new delisting norms; notifies fixed price mechanism as alternate route
- Govt considering foreign investment regulatory mechanism for FDI supervision
- India initiates anti-dumping probe on Chinese inert gas R-134a
- Regulatory, policy reforms crucial for future of India's pharma R&D: Report